English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Multiple studies have investigated the association of  interleukin-6  ( IL-6 ) gene polymorphisms and osteoarthritis (OA) risk, but failed to reach a consistent conclusion. Therefore, this study was designed to elucidate the association of  IL-6  polymorphisms and OA by a meta-analysis approach. Literature retrieval was carried out on PubMed, EMBASE, Web of Science, CNKI, and Wanfang databases. The strength of association was appraised by odds ratios (ORs) and 95% confidence intervals (95%CIs) in five genetic models. The data were merged by using RevMan 5.3 software. Ten studies with 4944 cases and 4651 controls were analyzed. Overall, no significant association was identified between  rs1800795  polymorphism and OA. Subgroup analysis by ethnicity and OA site also suggested  rs1800795  polymorphism was not associated with OA. For  rs1800796  polymorphism, G-allele and GG-genotype carriers appeared to have an increased risk to OA (G vs. C, OR = 1.66, 95%CI 1.30-1.96,  P  &lt; 0.01; GG vs. CC, OR = 1.75, 95%CI 1.07-2.84,  P  = 0.03; GG vs. GC + CC, OR = 1.82, 95%CI 1.42-2.34,  P  &lt; 0.01). Findings of this study indicate that the  rs1800795  polymorphism is not correlated to OA susceptibility, regardless of ethnicity or OA site. However,  rs1800796  polymorphism trends to be associated with susceptibility to OA.

Association of rs1800795 and rs1800796 polymorphisms in interleukin-6 gene and osteoarthritis risk: evidence from a meta-analysis